The London, Ontario, Daily/Nocturnal Hemodialysis Study

Area of Science:

• Nephrology
• Renal Replacement Therapy
• Clinical Outcomes Research

Background:

• Conventional thrice-weekly hemodialysis has limitations in managing end-stage renal disease.
• Quotidian hemodialysis, including daily and nocturnal regimens, offers potential advantages.
• The London Daily/Nocturnal Hemodialysis Study aimed to compare these modalities.

Purpose of the Study:

• To compare the clinical and economic outcomes of quotidian hemodialysis (daily and nocturnal) versus conventional hemodialysis.
• To evaluate improvements in urea clearance, nutrition, anemia, blood pressure, mineral metabolism, and quality of life.
• To conduct an economic analysis of home quotidian hemodialysis.

Main Methods:

• A prospective, comparative, nonrandomized study design.
• Patients assigned to daily (n=11) or nocturnal (n=12) hemodialysis, compared with matched conventional hemodialysis controls (n=22).
• Follow-up duration of 5-36 months, evaluating multiple clinical parameters and economic factors.

Main Results:

• Both quotidian hemodialysis regimens demonstrated superior weekly urea clearance compared to conventional hemodialysis.
• Significant improvements observed in nutrition, blood pressure, volume control, calcium/phosphorus management, and quality of life with quotidian therapy.
• Home quotidian hemodialysis showed substantial cost savings per quality-adjusted life-year.

Conclusions:

• Quotidian hemodialysis regimens are more effective than conventional hemodialysis in enhancing urea clearance.
• Home quotidian hemodialysis provides significant clinical benefits and economic advantages.
• Expansion of home quotidian hemodialysis is clinically and economically justified for end-stage renal disease management.